Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
|Articles|March 1, 2012
Gateway 2012: Meissner Filtration Products
Advertisement
Meissner Filtration Products
4181 Calle Tesoro
Camarillo, CA 93012
Phone: 800.391.9458
Int'l.: +1.805.388.9911
Questions?
Company description
Meissner is your source for advanced microfiltration and single-use systems. Focused on fluid technology innovation, we leverage our R&D efforts to offer our clients products that deliver advanced processing and fluid handling solutions for pharmaceutical and biopharmaceutical manufacturing.
Our One-Touch® single-use product portfolio demonstrates our commitment to manufacture innovative products. We introduced the industry's first slip agent-free PE biocontainers, TepoFlex®, thus reducing its extractables profile, and giving the biocontainer its remarkable visual clarity. We also delivered the industry's only multilayer PVDF biocontainer, FluoroFlex®, thus expanding the application of single-use systems beyond the limits of existing PE biocontainers, and into areas such as API storage.
Booth Invitations/Products Promoted
Meissner invites you to join us at INTERPHEX New York May 1st – 3rd. Meissner will be exhibiting in booth #2817. We will be featuring our One-Touch® single-use systems, including TepoFlex® PE biocontainer assemblies (2D & 3D configurations from 50 mL – 1,000 L), FluoroFlex® PVDF biocontainer assemblies (50 mL – 20 L), BioFlex® tubing assemblies (with optional PVDF or PES membranes filters for sterilizing grade applications, as well as a range of additional media for applications from clarification through sterilization) and FlexStation® rigid outer containers that complement TepoFlex® 3D biocontainers (from 100 L – 1,000 L). We will also feature the newly available QuaDrum™ containers (from 50 L – 200 L), FlexFill™ biocontainer transfer assemblies, and a host of FlexCessories™ to complement and support the One-Touch® portfolio (e.g. End-ported biocontainer hanging stand, ergonomic biocontainer hangers).
Meissner will also be exhibiting at the BIO International Convention, Boston, in booth #480, at ACHEMA, Frankfurt, Germany, in Hall 5, Stand E5, and at the BioProcess International Conference & Exhibition, Rhode Island, in booth #703.
Advertisement
Related to this article
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Advertisement
Advertisement